Masuda, Ken
Ishiki, Hiroto http://orcid.org/0000-0002-0800-2161
Yokomichi, Naosuke
Yamaguchi, Takuhiro
Ito, Tetsuya
Takatsu, Hana
Amano, Koji
Hiramoto, Shuji
Yamauchi, Toshihiro
Kawaguchi, Takashi
Mori, Masanori
Matsuda, Yosuke
Yamaguchi, Takashi
Funding for this research was provided by:
the Japanese Hospice Palliative Care Foundation and JSPS KAKENHI (JP20K16567)
Article History
Received: 4 January 2022
Accepted: 11 April 2022
First Online: 21 April 2022
Declarations
:
: The EASED study was performed in accordance with the ethical standards of the Helsinki declaration and the ethical guidelines for epidemiological research presented by the Ministry of Health, Labour and Welfare in Japan. The study protocol was reviewed and approved by the local institutional review boards of all participating institutions.
: Japanese law does not require individual informed consent from participants in a non-invasive observational trial. Therefore, we used an opt-out method rather than acquiring written or oral informed consent.
: Not applicable.
: Dr. Ishiki reports personal fees from Mundipharma, Morinaga Clinico, Merck Serono, and Guerbet Japan and non-financial support from Shionogi outside of the submitted work; Dr. Masuda reports personal fees from Chugai and AstraZeneca outside of the submitted work. All other authors state that they have no conflicts of interest.